Nucleofection of DCs to generate multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host

Molecular Therapy

Volumn 17, Issue 9, 2009, Pages 1616-1625

  Gerdemann, Ulrike ^a   Christin, Anne S ^a   Vera, Juan F ^a   Ramos, Carlos A ^a   Fujita, Yuriko ^a   Liu, Hao ^b   Dilloo, Dagmar ^c   Heslop, Helen E ^a   Brenner, Malcolm K ^a   Rooney, Cliona M ^a   Leen, Ann M ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; DNA; GAMMA INTERFERON; INTERLEUKIN 2;

ADENOVIRUS; ALLOIMMUNITY; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL ACTIVATION; CELL POPULATION; CELL PROLIFERATION; CELL SPECIFICITY; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EPSTEIN BARR VIRUS; FEASIBILITY STUDY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; PHENOTYPE; PLASMID; VIRUS INFECTION;

ADENOVIRIDAE; ANTIGENS, VIRAL; CELLS, CULTURED; CYTOMEGALOVIRUS; DENDRITIC CELLS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOTHERAPY; LEUKOCYTES, MONONUCLEAR; T-LYMPHOCYTES, CYTOTOXIC;

ADENOVIRIDAE; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 4;

EID: 69949190533     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2009.140     Document Type: Article

References (50)

1. Kim, YJ, Boeckh, M and Englund, JA (2007). Community respiratory virus infections in immunocompromised patients: Hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection. Semin Respir Crit Care Med 28 222-242.
2. Myers, GD, Bollard, CM, Wu, MF, Weiss, H, Rooney, CM, Heslop, HE et al. (2007). Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation. Bone Marrow Transplant 39: 677-686.
3. Kadakia, MP, Rybka, WB, Stewart, JA, Patton, JL, Stamey, FR, Elsawy, M et al. (1996). Human herpesvirus 6: Infection and disease following autologous and allogeneic bone marrow transplantation. Blood 87: 5341-5354.
4. Comoli, P, Binggeli, S, Ginevri, F and Hirsch, HH (2006). Polyomavirus-associated nephropathy: Update on BK virus-specific immunity. Transpl Infect Dis 8: 86-94.
5. de Pagter, PJ, Schuurman, R, Meijer, E, van Baarle, D, Sanders, EA and Boelens, JJ (2008). Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation. J Clin Virol 43: 361-366.
6. Heslop, HE, Ng, CY, Li, C, Smith, CA, Loftin, SK, Krance, RA et al. (1996). Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med 2: 551-555.
7. Comoli, P, Basso, S, Zecca, M, Pagliara, D, Baldanti, F, Bernardo, ME et al. (2007). Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation. Am J Transplant 7: 1648-1655.
8. Riddell, SR, Watanabe, KS, Goodrich, JM, Li, CR, Agha, ME and Greenberg, PD (1992). Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257: 238-241.
9. Walter, EA, Greenberg, PD, Gilbert, MJ, Finch, RJ, Watanabe, KS, Thomas, ED et al. (1995). Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333: 1038-1044.
10. Einsele, H, Rauser, G, Grigoleit, U, Hebart, H, Sinzger, C, Riegler, S et al. (2002). Induction of CMV-specific T-cell lines using Ag-presenting cells pulsed with CMV protein or peptide. Cytotherapy 4: 49-54.
11. Einsele, H, Roosnek, E, Rufer, N, Sinzger, C, Riegler, S, Löffler, J et al. (2002). Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 99: 3916-3922.
12. Peggs, KS, Verfuerth, S, Pizzey, A, Khan, N, Guiver, M, Moss, PA et al. (2003). Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet 362: 1375-1377.
13. Micklethwaite, KP, Clancy, L, Sandher, U, Hansen, AM, Blyth, E, Antonenas, V et al. (2008). Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation. Blood 112: 3974-3981.
14. Micklethwaite, K, Hansen, A, Foster, A, Snape, E, Antonenas, V, Sartor, M et al. (2007). Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 13: 707-714.
15. Leen, AM, Myers, GD, Sili, U, Huls, MH, Weiss, H, Leung, KS et al. (2006). Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med 12: 1160-1166.
16. Cobbold, M, Khan, N, Pourgheysari, B, Tauro, S, McDonald, D, Osman, H et al. (2005). Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J Exp Med 202: 379-386.
17. Feuchtinger, T, Lang, P, Hamprecht, K, Schumm, M, Greil, J, Jahn, G et al. (2004). Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy. Exp Hematol 32: 282-289.
18. Feuchtinger, T, Matthes-Martin, S, Richard, C, Lion, T, Fuhrer, M, Hamprecht, K et al. (2006). Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 134: 64-76.
19. Sili, U, Huls, MH, Davis, AR, Gottschalk, S, Brenner, MK, Heslop, HE et al. (2003). Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy. J Immunother 26: 241-256.
20. Straathof, KC, Leen, AM, Buza, EL, Taylor, G, Huls, MH, Heslop, HE et al. (2005). Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma. J Immunol 175: 4137-4147.
21. Leen, AM, Christin, A, Khalil, M, Weiss, H, Gee, AP, Brenner, MK et al. (2008). Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy. J Virol 82: 546-554.
22. Hislop, AD, Taylor, GS, Sauce, D and Rickinson, AB (2007). Cellular responses to viral infection in humans: Lessons from Epstein-Barr virus. Annu Rev Immunol 25: 587-617.
23. Comoli, P, Hirsch, HH and Ginevri, F (2008). Cellular immune responses to BK virus. Curr Opin Organ Transplant 13: 569-574.
24. Fujita, Y, Leen, AM, Sun, J, Nakazawa, Y, Yvon, E, Heslop, HE et al. (2008). Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapy. J Immunother 31: 665-674.
25. Berger, C, Jensen, MC, Lansdorp, PM, Gough, M, Elliott, C and Riddell, SR (2008). Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. J Clin Invest 118: 294-305.
26. Kennedy-Nasser, AA, Bollard, CM, Myers, GD, Leung, KS, Gottschalk, S, Zhang, Y et al. (2008). Comparable outcome of alternative donor and matched sibling donor hematopoietic stem cell transplant for children with acute lymphoblastic leukemia in first or second remission using alemtuzumab in a myeloablative conditioning regimen. Biol Blood Marrow Transplant 14: 1245-1252.
27. de Pagter, PJ, Schuurman, R, Visscher, H, de Vos, M, Bierings, M, van Loon, AM et al. (2008). Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: An important risk factor for clinical outcome. Biol Blood Marrow Transplant 14: 831-839.
28. Boeckh, M, Erard, V, Zerr, D and Englund, J (2005). Emerging viral infections after hematopoietic cell transplantation. Pediatr Transplant 9 Suppl 7: 48-54.
29. Peck, AJ, Englund, JA, Kuypers, J, Guthrie, KA, Corey, L, Morrow, R et al. (2007). Respiratory virus infection among hematopoietic cell transplant recipients: Evidence for asymptomatic parainfluenza virus infection. Blood 110: 1681-1688.
30. Ison, MG (2007). Respiratory viral infections in transplant recipients. Antivir Ther (Lond) 12(4 Pt B): 627-638.
31. Leen, A, Ratnayake, M, Foster, A, Heym, K, Ahmed, N, Rooney, CM et al. (2007). Contact-activated monocytes: Efficient antigen presenting cells for the stimulation of antigen-specific T cells. J Immunother 30: 96-107.
32. Landi, A, Babiuk, LA and van Drunen Littel-van den Hurk, S (2007). High transfection efficiency, gene expression, and viability of monocyte-derived human dendritic cells after nonviral gene transfer. J Leukoc Biol 82: 849-860.
33. Lenz, P, Bacot, SM, Frazier-Jessen, MR and Feldman, GM (2003). Nucleoporation of dendritic cells: Efficient gene transfer by electroporation into human monocyte-derived dendritic cells. FEBS Lett 538: 149-154.
34. MacGregor, RR, Boyer, JD, Ugen, KE, Lacy, KE, Gluckman, SJ, Bagarazzi, ML et al. (1998). First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: Safety and host response. J Infect Dis 178: 92-100.
35. MacGregor, RR, Boyer, JD, Ugen, KE, Tebas, P, Higgins, TJ, Baine, Y et al. (2005). Plasmid vaccination of stable HIV-positive subjects on antiviral treatment results in enhanced CD8 T-cell immunity and increased control of viral "blips". Vaccine 23: 2066-2073.
36. Cattamanchi, A, Posavad, CM, Wald, A, Baine, Y, Moses, J, Higgins, TJ et al. (2008). Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection system. Clin Vaccine Immunol 15: 1638-1643.
37. Weber, J, Boswell, W, Smith, J, Hersh, E, Snively, J, Diaz, M et al. (2008). Phase 1 trial of intranodal injection of a Melan-A/MART-1 DNA plasmid vaccine in patients with stage IV melanoma. J Immunother 31: 215-223.
38. Kutzler, MA and Weiner, DB (2008). DNA vaccines: Ready for prime time? Nat Rev Genet 9: 776-788.
39. Feuchtinger, T, Richard, C, Joachim, S, Scheible, MH, Schumm, M, Hamprecht, K et al. (2008). Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation. J Immunother 31: 199-206.
40. Binggeli, S, Egli, A, Schaub, S, Binet, I, Mayr, M and Steiger, J (2007). Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients. Am J Transplant 5: 1131-1139.
41. Heslop, HE, Ng, CY, Li, C, Smith, CA, Loftin, SK, Krance, RA et al. (1996). Longterm restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med 2: 551-555.
42. Rooney, CM, Smith, CA, Ng, CY, Loftin, S, Li, C, Krance, RA et al. (1995). Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345: 9-13.
43. Rooney, CM, Smith, CA, Ng, CY, Loftin, SK, Sixbey, JW, Gan, Y et al. (1998). Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 92: 1549-1555.
44. Steven, NM, Annels, NE, Kumar, A, Leese, AM, Kurilla, MG and Rickinson, AB (1997). Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J Exp Med 185: 1605-1617.
45. Haigh, TA, Lin, X, Jia, H, Hui, EP, Chan, AT, Rickinson, AB et al. (2008). EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets: LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell lines. J Immunol 180: 1643-1654.
46. Qu, L, Green, M, Webber, S, Reyes, J, Ellis, D and Rowe, D (2000). Epstein-Barr virus gene expression in the peripheral blood of transplant recipients with persistent circulating virus loads. J Infect Dis 182: 1013-1021.
47. Carbone, A, Gloghini, A and Dotti, G (2008). EBV-associated lymphoproliferative disorders: Classification and treatment. Oncologist 13: 577-585.
48. Mackinnon, S, Thomson, K, Verfuerth, S, Peggs, K and Lowdell, M (2008). Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells. Blood Cells Mol Dis 40: 63-67.
49. Leen, AM, Sili, U, Vanin, EF, Jewell, AM, Xie, W, Vignali, D et al. (2004). Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells. Blood 104: 2432-2440.
50. Vella, AT, Dow, S, Potter, TA, Kappler, J and Marrack, P (1998). Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci USA 95: 3810-3815.